NLRP3 and autoimmune polyendocrinopathy: Of significance, treatment of monocytes with SB (silibinin) downregulates NF-κB pathway and inactivates NLRP1/NLRP3 inflammasomes in pregnant women with PE (preeclampsia), suggesting a prospective therapeutical strategy for APS-related APOs via abrogating inflammation (67).